Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Women who have gestational diabetes mellitus (GDM) have elevated lifetime risks for the development of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD), compared with their peers. However, it is not known whether their risk of CVD is dependent upon the development of T2DM. Thus, we sought to evaluate the role of T2DM in determining vascular outcomes in women with previous GDM. RESEARCH DESIGN AND METHODS: All women in Ontario, Canada, with a live-birth pregnancy between April 1994 and March 2014 (n = 1,515,079) were stratified into the following four groups: women with GDM in whom T2DM subsequently developed (n = 15,585, median age 32 years); those with GDM in whom T2DM did not develop (n = 41,299; median age 32 years); women who did not have GDM but in whom T2DM developed (n = 49,397; median age 31 years); and those with neither GDM nor T2DM (n = 1,408,798; median age 30 years). Women were followed over a median time of 10.0 years for the development of microvascular and macrovascular outcomes. RESULTS: Among women who had GDM, only those in whom T2DM developed had an increased risk of vitrectomy/photocoagulation (hazard ratio [HR] 4.49, 95% CI 3.90–5.17), renal dialysis (HR 7.52, 5.24–10.81), and hospitalization for foot infection (HR 4.32, 3.42–5.46) (all P < 0.0001). However, for macrovascular outcomes, both women with GDM in whom T2DM developed and those in whom T2DM did not develop had increased risks of CVD (HR 2.82; 2.41–3.30; P < 0.0001; and HR 1.30; 1.07–1.59; P = 0.008, respectively) and coronary artery disease (HR 3.54; 2.96–4.23; P < 0.0001; and HR 1.41; 1.11–1.80; P = 0.005, respectively), although absolute event rates were very low. CONCLUSIONS: Women with GDM have an elevated risk of cardiovascular outcomes, even in the absence of T2DM. In contrast, microvascular risk emerges only in those in whom T2DM develops.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Women with a history of GDM are at an increased risk of developing type 2 diabetes mellitus (T2DM) postpartum and also have a significantly higher risk of developing a metabolic syndrome and cardiovascular diseases compared to women with normal glucose tolerance (NGT) in pregnancy [2,3].”
Citations
Cites
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60731-5 · Cited by 3,253 · cited 1×
“fold higher incidence of T2DM, compared with their peers (1).”
BackgroundBuchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123
Hux, J. E., Ivis, F., Flintoft, V., & Bica, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.512 · Cited by 1,290 · cited 1×
“The Ontario Diabetes Database (ODD) is a validated registry of physician-diagnosed nongestational diabetes mellitus that is derived using these data (18).”
BackgroundIncreased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
Shah, B. R., Retnakaran, R., & Booth, G. L. (2008) · Diabetes Care · doi:10.2337/dc08-0706 · Cited by 489 · cited 1×
“In an earlier study involving 8,191 women with GDM and 81,262 control subjects, adjustment for the development of T2DM attenuated the relationship between GDM and subsequent CVD, leading to the suggestion that intervening T2DM drives the enhanced cardiovascular risk observed in this population (15).”
ResultSelf-citationCarr, D. B., Utzschneider, K. M., Hull, R. L., Tong, J., Wallace, T. M., Kodama, K., Shofer, J. B., Heckbert, S. R., Boyko, E. J., Fujimoto, W. Y., et al. (2006) · Diabetes Care · doi:10.2337/dc05-2482 · Cited by 350
Lauenborg, J., Mathiesen, E., Hansen, T., Glümer, C., Jørgensen, T., Borch-Johnsen, K., Hornnes, P., Pedersen, O., & Damm, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1713 · Cited by 279
Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
Retnakaran, R., Qi, Y., Sermer, M., Connelly, P. W., Hanley, A. J. G., & Zinman, B. (2008) · Diabetes Care · doi:10.2337/dc08-0972 · Cited by 251 · cited 1×
“As the incidence of impaired glucose tolerance (IGT) is known to be much higher in womenwith previous GDM than in their peers (8,21), it is possible that the po-”
BackgroundSelf-citationRetnakaran, R., & Shah, B. R. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090569 · Cited by 194
Self-citationGlucose Intolerance in Pregnancy and Postpartum Risk of Metabolic Syndrome in Young Women
Retnakaran, R., Qi, Y., Connelly, P. W., Sermer, M., Zinman, B., & Hanley, A. J. G. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1990 · Cited by 190 · cited 1×
“postpartum (24,28,29), suggesting a chronicity that could provide sufficient duration of exposure to contribute to atherosclerosis.”
BackgroundSelf-citationMetabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis
Xu, Y., Shen, S., Sun, L., Yang, H., Jin, B., & Cao, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087863 · Cited by 163
Research works printed but not linked: 1
- Kralji, 2000, Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario, Ont Med Rev, 67, 33
Cited by
Items 101–181 of 181
Kishimoto, M., Tamaru, S., & Odawara, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-23404-1 · Cited by 7
A terhességi cukorbetegség rövid története, kockázati tényezői és diagnosztikája napjainkban
Al‐Aissa, Z., Hadarits, O., Rosta, K., Zóka, A., Rigó, J. J., Firneisz, G., & Somogyi, A. (2017) · Orvosi Hetilap · doi:10.1556/650.2017.30651 · Cited by 7
Arya, S., Ye, C., Connelly, P. W., Hanley, A. J., Sermer, M., Zinman, B., & Retnakaran, R. R. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.03.009 · Cited by 7
Self-citationMaresh, M., Lawrence, J. M., Scholtens, D. M., Kuang, A., Lowe, L. P., Deerochanawong, C., Sacks, D. A., Lowe, W. L., Dyer, A. R., & Metzger, B. E. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00468-2 · Cited by 7
Mehrabadi, A., Yu, Y., Grandi, S. M., Platt, R. W., & Filion, K. B. (2025) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.15022 · Cited by 6
Sex Differences in Cardiovascular Disease and Unique Pregnancy-Associated Risk Factors in Women
O’Kelly, A. C., & Honigberg, M. C. (2020) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-020-00860-8 · Cited by 7
Simon, J., Goueslard, K., Arveux, P., Bechraoui‐Quantin, S., Petit, J., & Quantin, C. (2021) · Cancers · doi:10.3390/cancers13020308 · Cited by 6
Sonaglioni, A., Casieri, F., Nicolosi, G. L., Bianchi, S., & Lombardo, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041271 · Cited by 5
Uteroplacental microvascular remodeling in health and disease
Li, R., Ma, L., Geng, Y., Chen, X., Zhu, J., Zhu, H., & Wang, D. (2025) · Acta Physiologica · doi:10.1111/apha.70035 · Cited by 5
“182 However, the long-term impact of diabetes during pregnancy on women remains controversial, 159,162,183 highlighting the need for long-term follow-up studies with large sample sizes.”
Adeoye, I. A., Adedapo, K. S., Sonuga, O. O., Fagbamigbe, A. F., Adeleye, J., Olayemi, O. O., Omigbodun, A. O., & Bamgboye, A. E. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095252 · Cited by 6
“29 30 31–33 Several studies have also shown that GDM increases the risk of overweight, obesity, metabolic syndrome and type 2 diabetes in the offspring in later life.”
Perspective on the nursing management for gestational diabetes mellitus: A perspective
Fan, Y.-T., Wang, X., Wang, Q., Luo, X., & Cao, J. (2025) · Medicine · doi:10.1097/md.0000000000041862 · Cited by 5
“10] Genetic predisposition plays a crucial role, as evidenced by higher incidence rates in women with a family history of GDM. Lifestyle factors such as diets high in calories, limited physical activity, and excessive body weight significantly contribute to the risk.”
Cardiovascular Health During Pregnancy: Future Health Implications for Mothers
Catov, J. M., Bairey-Merz, N., & Rich-Edwards, J. W. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0116-x · Cited by 5
Souza, L. R. D., Ye, C., Hanley, A. J., Connelly, P. W., Sermer, M., Zinman, B., & Retnakaran, R. R. (2017) · Clinical Endocrinology · doi:10.1111/cen.13510 · Cited by 5
Self-citationBülent, C. A. N., Doğanşen, S. Ç., Yalın, G. Y., & Dınççağ, N. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2002-65 · Cited by 5
Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk
Retnakaran, R. R., Sriram, U., Wijeyaratne, C. N., Hod, M., & Kapur, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30208-0 · Cited by 5
Self-citationVilmi‐Kerälä, T. (2018) · Tampere University Institutional Repository (Tampere University) · Cited by 5
Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep
Alkhatib, B., Ciarelli, J. N., Ghnenis, A. B., Pallas, B. D., Olivier, N. B., Padmanabhan, V., & Vyas, A. K. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00763.2023 · Cited by 4
From Pregnancy to Postpartum: The Cardiovascular Risks Associated with Gestational Diabetes
Sharma, R., Singh, U., Kamal, R., & Kumar, R. (2025) · Current Cardiology Reviews · doi:10.2174/011573403x354645250329171327 · Cited by 4
“Specifically, some studies have shown that women with GDM only experience CVD if they progress to T2D; nevertheless, other investigations have contended that an elevated risk of cardio-vascular disease might appear even in the absence of diabetes [7-9].”
The obstetrician's role in preventing cardiometabolic disease
Hirst, J. E., Nagraj, S., Henry, A., Mackillop, L. H., Norton, R., & Kennedy, S. (2019) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12600 · Cited by 4
Hu, C., Zhang, Y., Lin, L., Wang, S., Du, R., Zhang, J., Qi, H., Li, M., Zhu, Y., Huo, Y., et al. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13222 · Cited by 4
“Results of our analysis provide evidence that gestational hyperglycemia is an independent risk factor for CVD and partly consistent with previous studies.(11,12,19,20) In our study, even if women with gestational hyperglycemia do not develop type 2 diabetes, they still have a higher CVD risk, suggesting that the incre…”
MethodResultRecurrent gestational diabetes: Breaking the transgenerational cycle with lifestyle modification
Liney, T. E. J., Shah, N. M., & Singh, N. (2022) · Wiener klinische Wochenschrift · doi:10.1007/s00508-022-02004-3 · Cited by 4
Zhang, X., Wu, H., Lau, E. S. H., Fan, B., Tsoi, K. Y., Tam, C. H. T., Yang, A., Shi, M., Chow, E., Kong, A. P. S., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14167 · Cited by 4
Ronald, C. W., Chow, E. W., Ng, N. Y. H., Sugiyama, T., Deng, Y., Tam, W. H., Lau, S., Poon, L. C., Zhang, C., & Sriram, U. (2025) · Journal of Diabetes Investigation · doi:10.1111/jdi.70095 · Cited by 3
“Although GDM is also associated with a variety of metabolic outcomes including higher risk of cardiovascular disease (CVD) and renal dysfunction 89,90 , studies have highlighted that the subsequent risk of renal disease is mediated via development of diabetes, whereas CVD less so 91 .”
Kidney Dysfunction Following Gestational Diabetes Mellitus
Hamill, M., Fernandez, C. G., Mitsigiorgi, R., Mansukhani, T., Nicolaides, K. H., & Bramham, K. (2025) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000802 · Cited by 3
Guo, J., Lv, W., Jiang, S., Tang, Y., Long, Q., Yang, J., Wiley, J. A., & Parry, M. J. E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-049625 · Cited by 3
Impact of prior gestational diabetes on long-term type 2 diabetes complications
Cui, Y., Marshall, A., Tsaih, S., & Palatnik, A. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108282 · Cited by 4
Raets, L., Hoorenbeeck, K. V., Maes, T., Vercammen, C., Block, C. E. M. D., Dirinck, E. L., Pottelbergh, I. V., Wierckx, K., Laenen, A., Bogaerts, A., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12031025 · Cited by 3
“GDM have a significantly higher risk of developing metabolic syndrome and cardiovascular disease, compared to normal glucose tolerant women [6,7].”
BackgroundThe Early Detection in Gestational Diabetes Mellitus at Indonesia Primary Health Care
Dewi, E. R., Prasetyo2, B., Laksana2, M. A. C., Joewono2, H. T., & Wittiartika1, I. D. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i2.3146 · Cited by 3
Gestational Diabetes Mellitus in Asian Indian Population: Pathophysiology and Mechanism
Deepa, M., & Chandrasekaran, S. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-023-00367-8 · Cited by 3
Luo, J., Tong, L., Xu, A., He, Y., Huang, H., Qiu, D., Peng, X., Zhou, Y., Guo, X., Chen, H., et al. (2025) · Environmental Geochemistry and Health · doi:10.1007/s10653-025-02833-x · Cited by 2
“In addition, women with GDM are at higher risk of developing type 2 diabetes mellitus (T2DM) and altered glucose metabolism in the future (Hwu et al., 2016; Retnakaran & Shah, 2017; Sweeting et al., 2022).”
Gestational Diabetes Mellitus and Incident Kidney Disease: A Nationwide French Cohort Study
Echouffo-Tcheugui, J. B., Tapia, S., Bechraoui‐Quantin, S., Cottenet, J., Jaar, B. G., Simon, E. G., & Quantin, C. (2026) · Kidney360 · doi:10.34067/kid.0000001068 · Cited by 2
Maurer, G. S., O'NEILL, B. T., Jalal, D. I., & Stanhewicz, A. E. (2026) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01080.2025 · Cited by 2
Christensen, M. H., Vinter, C. A., Petersen, M. H., Andersen, M. S., Grauslund, J., & Jensen, D. M. (2026) · Diabetes Care · doi:10.2337/dc25-3074 · Cited by 2
Bahardoust, M., Rahimpour, E., Shokohyar, S., Aghakhani, Z., Delpisheh, A., Shamohammadi, M., Haghmoradi, M., & Ghaffari, A. (2026) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70208 · Cited by 2
“Studies have shown that women with GDM are at higher risk of metabolic syndrome and microvascular complications [25, 47, 48].”
Lv, X., Lin, G., Zhang, Y., Yuan, K., Liang, T., Liu, R., Du, Y., Yu, H., & Sun, S. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117006 · Cited by 2
Special Considerations in the Management of Diabetes in Women
McNeill, D., & Herbst, R. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6818 · Cited by 2
“17 This same study also showed that patients with GDM who did develop diabetes were at the highest risk of CVD.”
Cardiometabolic Risks in Gestational Diabetes Mellitus: A Mini-Review
Renugasundari, M., Pal, G. K., Chaturvedula, L., Nanda, N., & Harichandrakumar, K. (2022) · International Journal of Clinical and Experimental Physiology · doi:10.5530/ijcep.2022.9.2.16 · Cited by 1
Cardiometabolic Function in Women
Joksimović, J., Novakovic, J. N., Jeremic, N. S., & Bradić, J. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-39928-2_12 · Cited by 1
Risk of cardiovascular events after gestational diabetes: a retrospective population study
Seghieri, G., Gualdani, E., Campesi, I., Franconi, F., Francesconi, P., & Cianni, G. D. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02297-y · Cited by 1
“Similarly, in a large cohort study of 1,515,079 Canadian women, those with GDM, regardless of the development of Post-GD, had an increased risk of CVD after pregnancy, being, however, such a risk doubled in presence of post-gestational diabetes [12].”
Qian, F., Yang, J., Tobias, D. K., Ley, S. H., Chavarro, J. E., Liu, G., Chen, Z., Yeung, E. H., Sun, Q., Willett, W. C., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.038936 · Cited by 1
“12,31,32 In a separate study, we found that attainment of optimal modifiable factors was associated with a >90% lower risk of developing T2D among women with a history of GD. 33 Hence, we did not adjust for the development of T2D in our study, as this likely mediated a significant proportion of the…”
Wei, Z., Yan, T., Wu, Y., Shang, L., Han, S., & Li, M. (2025) · Biological Research For Nursing · doi:10.1177/10998004251366590 · Cited by 1
“…recognized as a metabolic condition closely associated with adverse cardiovascular outcomes (Daly et al., 2018; Fadl et al., 2014; Goueslard et al., 2016; Kaul et al., 2015; Kessous et al., 2013; McKenzie-Sampson et al., 2018; Retnakaran & Shah, 2017; Shah et al., 2008; Tobias et al., 2017).”
A Review of Traditional and Non-Traditional Cardiovascular Risk Factors in Women
Vasanthakumar, S. A., Paleri, S., Aldous, E., Khanna, S., Nandurkar, R., Davis, E., Lin, A., & Nerlekar, N. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s574244 · Cited by 1
Gestational and postpartum maternal consequences of gestational diabetes mellitus
Wu, C.-K., Chang, C.-Y., Seow, K., Huang, Y.-C., Chuang, C.-W., & Chen, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1809244 · Cited by 1
Mothers with HIP – The short term and long-term impact, what is new?
Mecacci, F., Ottanelli, S., & Petraglia, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.039 · Cited by 1
Universal testing for hyperglycemia in pregnancy
Kapur, A., & Mahmood, T. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817921-5.00017-5 · Cited by 1
Mainland, R., Wen, S. W., Tan, H., Zhou, S., Ye, C., Shen, M., Smith, G. N., WALKER, M. C., & Retnakaran, R. R. (2021) · Women s Health Reports · doi:10.1089/whr.2021.0006 · Cited by 1
Self-citationComité de Embarazo. Importancia de la reclasificación posparto en la diabetes mellitus gestacional
Rodríguez, M. E., Favetto, V. K., Parra, B. V., Sucani, S. M., Mendes, P., Argerich, M. I., Fernández, P., Martín, C. G., Hermida, M., Lapertosa, S., et al. (2024) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v58i1sup.757 · Cited by 1
Gianatti, E., Davis, W. A., & Davis, T. M. E. (2024) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2024.108811 · Cited by 1
Long-term health in women who have had gestational diabetes or an LGA newborn
Hakkarainen, H. (2019) · UEF eRepo (University of Eastern Finland) · Cited by 1
Guo, X., Wang, R., Xiang, J., Jiang, F.-N., Zhang, J., Peng, X., Zheng, X., Dai, Y., & Cai, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-4630886/v1 · Cited by 1
Lu, J., Xu, H., & Xu, Q. (2026) · Research Square · doi:10.21203/rs.3.rs-10222798/v1 · Cited by 1
“High-parity High-parity women should receive attention to renal function given the progressive CKD gradient [33].”
Novel biomarkers associated with gestational diabetes mellitus and metabolic outcomes of pregnancy.
Sukumar, N. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33742723
Carew, A. S. (2018) · DalSpace (Dalhousie University)
SOCIOECONOMIC AND HEALTH STATUS OF PREGNANT DIABETIC WOMEN
Jadhav, S. R. M. A. K. J. S. R. M. A. K., & ijrbat (2019) · International Journal of Researches in Biosciences and Agriculture Technology · doi:10.29369/ijrbat.2019.01.i.0004
Harreiter, J., Desoyé, G., van Poppel, M. N. M., Kautzky‐Willer, A., Dunne, F., Corcoy, R., Devlieger, R., Simmons, D. S., Adelantado, J. M., Damm, P., et al. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01322-y
Lencioni, C. (2019) · The Journal of AMD · doi:10.36171/jamd19.22.3.07
Adil, S., Hidayat, I., Ali, A., Ali, S., Ayaz, H., Ayub, M., & Ayub, F. (2022) · Journal of Gandhara Medical and Dental Science · doi:10.37762/jgmds.9-4.356
Exploring the Immune-Related Senescence biomarkers in Predicting Gestational Diabetes MellitusPreprint
Gan, Y., Mao, J., He, Y., Chen, Z., Fan, B., Shi, Q., & Qi, H. (2024) · Preprints.org · doi:10.20944/preprints202404.0967.v1
Raets, L., Hoorenbeeck, K. V., Maes, T., Lee, D., Block, C. E. M. D., Dirinck, E. L., Pottelbergh, I. V., Wierckx, K., Laenen, A., Bogaerts, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf275
Liu, Y., Yan, J., Li, M., & Zhao, D. (2025) · Clinical ophthalmology · doi:10.2147/opth.s521323
Hu, R., & Mi, Y. (2025) · Journal of Contemporary Medical Practice · doi:10.53469/jcmp.2025.07(08).34
Zhang, L., Qiu, Y., Huang, Y., Ainiwan, D., Zhou, H., Cheng, H., Alifu, X., Zhuang, Y., Chi, P., Chen, D., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01958-4
“Another study conducted in Canada reported an elevated risk of CHD was observed in women with GDM regardless of the presence or absence of T2DM [7].”
IMPLICAÇÕES MATERNAS E FETAIS DA DIABETES GESTACIONAL
lago, M. S. V., dos Santos, C., Prado, V. C. D. A., Soares, I. D. S., Lauria, S. M., Garavito, D. F. V., Rocha, C. S., & Alves, M. M. (2025) · Aurum Editora eBooks · doi:10.63330/aurumpub.014-036
Retnakaran, R., & Shah, B. R. (2022) · Figshare · doi:10.6084/m9.figshare.21500776
Self-citationMercier, R. (2018) · Corpus Université Laval (Université Laval)
Mussa, J. (2024) · eScholarship@McGill (McGill) · doi:10.82308/54537
Factores de riesgo en la diabetes gestacional: revisión sistemática
Monsalve, L. B., Martinez, C. P. G., & Hernandez, A. C. V. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Alkahtani, K., Mahjoub, M. M., Takroni, Z. M., Ibrahim, K., Zeyad, L. A., Tayb, M. S., Alteibawi, M. A., Almuzayen, H., Sahl, Y. M., Rabeh, H. M. A., et al. (2026) · Cureus · doi:10.7759/cureus.102898
Goedeke, S. M. (2024) · Tuwhera (Auckland University of Technology)
Feng, J., Lu, D., Wang, L., Fan, D., Zhou, Z., Chen, G., Li, P., Ou, R., Chen, B., Yang, J., et al. (2026) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000341
Merino, D. V. V. (2025) · Universidad Industrial de Santander
Ninalaya, M. (2025) · Mspace (University of Manitoba)
Echouffo-Tcheugui, J. B., McCormack, D., Ke, C., Retnakaran, R. R., & Shah, B. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71119
“Whether and to what extent an antecedent of GDM and/or GHTD contributes to the excess CVD risk among women with T2DM largely remains unknown [11].”
Self-citationLimruangrong, P., Ukhawounam, U., Pornsuriyasak, P., & Matthews, A. K. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-09705-x
“Nevertheless, GDM is associated with substantial long-term health risks, including future type 2 diabetes and cardiovascular disease, which may confer ongoing psychological vulnerability beyond the immediate postpartum period [80, 81].”
Gestational Diabetes and Postpartum Cardiovascular, Kidney, and Metabolic Disorders
Liu, L., Lu, J. A., Velásquez, E. E. M., Ananth, C. V., Nguyen, M. H., & Williams, M. A. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.28578
Maurer, G. S., Whitaker, K. M., Jalal, D. I., & Stanhewicz, A. E. (2026) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00541.2026
Maurer, G. S., Schwartz, K., Jalal, D. I., & Stanhewicz, A. E. (2026) · Experimental Physiology · doi:10.1113/ep093827
“…also have an increased likelihood of developing cardiovascular disease (CVD) within the first decade postpartum and exhibit a higher risk of CVD-related mortality in comparison to healthy control (HC) women who experienced uncomplicated pregnancies (Kramer et al., 2019; Retnakaran & Shah, 2017).”
Gestational Diabetes: Management, Pharmacist Control, and Nursing Intervention Plans
Mehdaly, A. A. A. (2024) · Review of Contemporary Philosophy
Metadata
- Authors
- Retnakaran, R., & Shah, B. R.
- Affiliations
- Mount Sinai Hospital (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Shah, Baiju R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-11-07
- Volume
- 40
- Issue
- 1
- Pages
- 101-108
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2553073169
- Cited by
- 167
- References
- 33
- Citations by year
- 2026: 14 · 2025: 16 · 2024: 15 · 2023: 16 · 2022: 23 · 2021: 18 · 2020: 16 · 2019: 20 · 2018: 19 · 2017: 10
- FWCI
- 21.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, type 2 diabetes, cardiovascular disease, diabetic retinopathy, diabetic nephropathy, dialysis, foot infection, coronary artery disease, microvascular complications, macrovascular complications, women, diabetes risk stratification, live birth, hospitalization, vitrectomy, photocoagulation, coronary angiography
- MeSH terms
- Adult, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Kidney Diseases, Ontario, Pregnancy, Retinal Diseases, Risk Factors, Time Factors, Proportional Hazards Models, Case-Control Studies, Diabetes, Gestational, Postpartum Period, Microvessels
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.